'WeChat WeQuit' Smoking Cessation Program

Smoking Cessation Clinical Trial

Official title:

The Efficacy of WeChat Based Interventions ('WeChat WeQuit' Program) for Smoking Cessation in China: a Randomized Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03169686
• Other study ID #: 2017S015
• Status: Completed
• Phase: N/A
• Start date: March 19, 2020
• Est. completion date: November 16, 2022

Study information

• Verified date: November 2022
• Source: Sir Run Run Shaw Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This proposed project is to assess whether WeChat-based smoking cessation interventions ('WeChat WeQuit' program) will be effective at helping people in China who smoke, to quit.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2000
• Est. completion date: November 16, 2022
• Est. primary completion date: November 16, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Daily Chinese cigarette smokers.

2. 18 years of age and older living.

3. Being able to read and write in Chinese.

4. Owning a smartphone and knowing how to use WeChat.

5. Willing to make an attempt to quit smoking in the next month.

6. Willing to provide informed consent to participate in the study.

Exclusion Criteria:

1. Nonsmokers.

2. Smokers without attempt to quit.

3. Below 18 years old.

4. Unable to use smartphone and WeChat.

5. Unable to read and write in Chinese.

Related Conditions & MeSH terms

• Cigarette Smoking
• Smoking Cessation

Intervention

Behavioral:
• Cognitive and Behavioral Intervention
Participants who allocate to the intervention group will receive regular smoking cessation related information by professional team.

Locations

Country	Name	City	State
China	Yanhui Liao	Hanzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Sir Run Run Shaw Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Smoking Reduction and Participation	Reductions in number of cigarettes smoked per day and rates of participation in and completion of smoking-cessation programs.	26 weeks
Primary	Biochemically Validated Continuously Abstinence	The primary outcome will be biochemical validation of self-reported 26-week continuous smoking abstinence	26 weeks
Secondary	Self-reported 7-day Point Abstinence	Self-reported 7-day point-prevalence abstinence at week 1, 4, 8, 12, 16, 20 and 26 after quit date.	26 weeks
Secondary	Self-reported Continuous Abstinence	Self-reported continuous smoking abstinence rate at weeks 4, 8, 12, 16, 20, and 26 after the quit date.	26 weeks